Showing results (331-340 of 480) with videos related to
Sort By:
Pageof 48
Journal of Clinical Gastroenterology|February 28, 2013
Predicting early and sustained virological responses in prior nonresponders to pegylated interferon alpha-2b plus ribavirin retreated with peginterferon alpha-2a plus ribavirin and the benefit-risk ratio of retreatmentPatrick Marcellin, Antonio Craxi, Carlos E Brandao-Mello, et al.Hepatology (Baltimore, Md.)|March 29, 2014
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failuresJasmohan S Bajaj, Jacqueline G O'Leary, K Rajender Reddy, et al.Journal of Hepatology|September 15, 2014
Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGETStuart C Gordon, Andrew J Muir, Joseph K Lim, et al.Gut Microbes|November 8, 2021
The Mucosally-Adherent Rectal Microbiota Contains Features Unique to Alcohol-Related CirrhosisTing-Chin David Shen, Scott G Daniel, Shivali Patel, et al.Journal of Viral Hepatitis|January 17, 2025
DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral TherapyAmit G Singal, K Rajender Reddy, Massimo Colombo, et al.Gastroenterology|September 18, 2024
A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in CirrhosisTracey L Marsh, Neehar D Parikh, Lewis R Roberts, et al.The American Journal of Gastroenterology|August 30, 2019
Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of LifeZobair M Younossi, Maria Stepanova, Eric J Lawitz, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 29, 2021
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH StudyMary J Thomson, Marina Serper, Vandana Khungar, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 14, 2021
Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant RecipientsLauren N Krumeich, Jenna Mancinelli, Andy Cucchiara, et al.Journal of Vascular and Interventional Radiology : JVIR|January 18, 2006
Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creationMaxim Itkin, Scott O Trerotola, S William Stavropoulos, et al.Pageof 48